Table of Content


List of Tables
List of Figures
Introduction
Global Markets Direct Report Coverage
Down Syndrome - Overview
Down Syndrome - Therapeutics Development
Pipeline Overview
Pipeline by Companies
Pipeline by Universities/Institutes
Products under Development by Companies
Products under Development by Universities/Institutes
Down Syndrome - Therapeutics Assessment
Assessment by Target
Assessment by Mechanism of Action
Assessment by Route of Administration
Assessment by Molecule Type
Down Syndrome - Companies Involved in Therapeutics Development
AC Immune SA
Advanced Medical Projects
Aelis Farma SAS
Alzheon Inc
Annovis Bio Inc
Avanti Biosciences Inc
Balance Therapeutics Inc
Eisai Co Ltd
Elixirgen Therapeutics LLC
F. Hoffmann-La Roche Ltd
KinoPharma Inc
ManRos Therapeutics
NeuroCircuit Therapeutics Inc
Neuroscent Inc
San Biotechnology Co Ltd
Down Syndrome - Drug Profiles
ABI-02 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
ACI-24 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Down Syndrome - Dormant Projects
Down Syndrome - Discontinued Products
Down Syndrome - Product Development Milestones
Featured News & Press Releases
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer



List of Figures


Number of Products under Development for Down Syndrome, H1 2020
Number of Products under Development by Companies, H1 2020
Number of Products under Development by Universities/Institutes, H1 2020
Number of Products by Top 10 Targets, H1 2020
Number of Products by Stage and Top 10 Targets, H1 2020
Number of Products by Top 10 Mechanism of Actions, H1 2020
Number of Products by Stage and Top 10 Mechanism of Actions, H1 2020
Number of Products by Routes of Administration, H1 2020
Number of Products by Stage and Routes of Administration, H1 2020
Number of Products by Molecule Types, H1 2020
Number of Products by Stage and Molecule Types, H1 2020


List of Tables


Number of Products under Development for Down Syndrome, H1 2020
Number of Products under Development by Companies, H1 2020
Number of Products under Development by Universities/Institutes, H1 2020
Products under Development by Companies, H1 2020
Products under Development by Universities/Institutes, H1 2020
Number of Products by Stage and Target, H1 2020
Number of Products by Stage and Mechanism of Action, H1 2020
Number of Products by Stage and Route of Administration, H1 2020
Number of Products by Stage and Molecule Type, H1 2020
Down Syndrome - Pipeline by AC Immune SA, H1 2020
Down Syndrome - Pipeline by Advanced Medical Projects, H1 2020
Down Syndrome - Pipeline by Aelis Farma SAS, H1 2020
Down Syndrome - Pipeline by Alzheon Inc, H1 2020
Down Syndrome - Pipeline by Annovis Bio Inc, H1 2020
Down Syndrome - Pipeline by Avanti Biosciences Inc, H1 2020
Down Syndrome - Pipeline by Balance Therapeutics Inc, H1 2020
Down Syndrome - Pipeline by Eisai Co Ltd, H1 2020
Down Syndrome - Pipeline by Elixirgen Therapeutics LLC, H1 2020
Down Syndrome - Pipeline by F. Hoffmann-La Roche Ltd, H1 2020
Down Syndrome - Pipeline by KinoPharma Inc, H1 2020
Down Syndrome - Pipeline by ManRos Therapeutics, H1 2020
Down Syndrome - Pipeline by NeuroCircuit Therapeutics Inc, H1 2020
Down Syndrome - Pipeline by NeuroNascent Inc, H1 2020
Down Syndrome - Pipeline by San Biotechnology Co Ltd, H1 2020
Down Syndrome - Dormant Projects, H1 2020
Down Syndrome - Discontinued Products, H1 2020